Pricing Log in Create free account

Coya Therapeutics, Inc. (COYA) vs MAIA Biotechnology, Inc. (MAIA)

Coya Therapeutics, Inc. and MAIA Biotechnology, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and MAIA Biotechnology, Inc. are of similar size ($65.9M and $64.2M). MAIA Biotechnology, Inc. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 12 metrics below, Coya Therapeutics, Inc. leads on 6 and MAIA Biotechnology, Inc. on 6.

Valuation

Metric COYA MAIA Biotechnology median
P/E n/m n/m 10.26
P/S 8.25 n/m 9.18
P/B 1.53 3.03 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 4.48 n/m 8.98
Earnings yield (37.94%) (61.14%) (34.89%)
Free cash flow yield (26.87%) (36.04%) (24.52%)

Profitability

Metric COYA MAIA Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (288.70%) 0.00% 0.00%
Net margin (270.22%) 0.00% 0.00%
Free cash flow margin (221.64%) 0.00% 0.00%
Return on equity (60.54%) (218.68%) (50.12%)
Return on assets (53.66%) (136.67%) (45.60%)
Return on invested capital (15,230.92%) 0.00% 0.00%

Growth

Metric COYA MAIA Biotechnology median
Revenue growth (TTM) 108.35% — 6.26%
EPS growth (last fiscal year) (29.59%) 33.33% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA MAIA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 4.51 4.89
Net debt to EBITDA 2.08 0.36 1.01

Dividend

Metric COYA MAIA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COYA MAIA Biotechnology median
Market cap 65.92m 64.22m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack